John M. Centanni

John M. Centanni is an experienced regulatory affairs professional with a robust background in the biotechnology and pharmaceutical industries. Currently serving as Chief Compliance Officer at Deverra Therapeutics since September 2024, Centanni has previously held prominent roles including Vice President of Regulatory Affairs at Coya Therapeutics, Inc., and Principal Consultant for Global Regulatory Affairs at Cardinal Health. Earlier experiences encompass leadership positions at Neurona Therapeutics and AxoGen, Inc., as well as academic involvement as Faculty Associate in the Master of Science in Biotechnology Program. Centanni's extensive regulatory expertise is underscored by a solid educational foundation, holding a Master’s degree in Biomedical Sciences from Hood College and a Bachelor’s degree in Biology from the University of Wisconsin Oshkosh.